Pharmacology
Sort by:
The North American Thrombosis Forum (NATF)
The Perils of Discontinuing Anticoagulation in Afib — Findings from the GARFIELD-AF Registry
FEATURING
Samuel Goldhaber
- 2,228 views
- January 13, 2022
- 9
San Diego Cardiovascular Interventions 2021
Forget Preload: Intravenous ADP Antagonist for PCI
FEATURING
Mitul Patel
- 225 views
- September 21, 2021
- 1
New York Transcatheter Valves 2021
Top Ten Advances in Transcatheter Valve Therapy 2021
FEATURING
Samin Sharma
- 920 views
- January 20, 2022
- 4
Mount Sinai Advanced Innovations in Heart Failure
Management of Atrial Fibrillation in Heart Failure: EAST-AFNET4, CABANA Trial and RAFT-AF Trials
FEATURING
Vivek Reddy
- 1,712 views
- March 2, 2022
- 9
The Texas Heart Institute
Coronary Artery Disease and the Use of Aspirin: What Is the Efficacy of Use for Primary Prevention?
FEATURING
Eduardo Hernandez
- 994 views
- April 22, 2021
- 4
The Texas Heart Institute
Silent Leaflet Thrombosis After TAVR: Is Absence of Anticoagulation Therapy the Main Cause of SLT? How to Treat it?
FEATURING
Zvonimir Krajcer
- 420 views
- March 18, 2021
- 5
4TS Global
Latest Clinical Trials in Cardiovascular Medicine: What Did We Learn from ISCHEMIA, ORION, COLCOT, TICO, VOYAGER PAD and Other Trials?
FEATURING
Omar Hallak
- 605 views
- March 26, 2021
- 3
Complex Coronary Valvular and Vascular Cases Conference
Optimal Duration of DAPT: Update on DAPT Guidelines
FEATURING
Roxana Mehran
- 1,030 views
- August 16, 2016
- 5
Complex Coronary Cases
Case of PCI in High Bleeding Risk Patients
FEATURING
George Dangas
- 243 views
- July 15, 2022
- 2
16th Annual Heart Failure Holiday Symposium
Cardiac Amyloidosis vs. Cardiorenal Syndrome: How to Diagnose and Treat the Patients?
FEATURING
Martha Grogan
- 619 views
- February 18, 2021
- 7
Keck School of Medicine of USC
Newer Therapies in Management of Chronic Heart Failure: Roles of SGLT2 Inhibitors and Vericiguat
FEATURING
Kruti Pandya
- 290 views
- December 28, 2020
The North American Thrombosis Forum (NATF)
AHA 2020 Trial Takeaways: Should Rivaroxaban Be Used in Patients with Bioprosthetic Valves? Can Vitamin D, Omega-3 Supplementation and Early Ablation Decrease the Incidence of Afib and Other CV Events?
FEATURING
Christian Cruff
- 623 views
- December 17, 2020
- 4
Complex Coronary Cases
Antiplatelet Therapies for CAD in 2021: Interventional Cardiology Board Review
FEATURING
Joseph Sweeny
- 562 views
- August 24, 2021
- 4
Piedmont Heart Institute Napa Valley Cardiology Conference
The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure
FEATURING
Thomas Deering
- 1,333 views
- November 15, 2019
- 10
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias
Outpatient Management of Atrial Fibrillation
FEATURING
Nicholas Olson
- 1,111 views
- May 17, 2019
- 13
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
NOAC Therapy for CV Disease: AFib and Beyond
FEATURING
Daniel Blanchard
- 385 views
- January 30, 2020
- 3
California Heart Rhythm Symposium
Atrial Fibrillation and the Risk of Stroke
FEATURING
Jared Bunch
- 900 views
- November 23, 2018
- 4